Cancers, Vol. 12, Pages 1095: ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms
Conclusion: RS associated with MYCN amplification, ATR loss or PARP inhibition increases sensitivity to the ATR inhibitor VE-821. These findings suggest a potential therapeutic strategy for the treatment of HR-NB.
Source: Cancers - Category: Cancer & Oncology Authors: Harriet E. D. Southgate Lindi Chen Deborah A. Tweddle Nicola J. Curtin Tags: Article Source Type: research
More News: Ataxia | Brain | Cancer | Cancer & Oncology | Childhood Cancer | Gastroschisis Repair | Genetics | Neuroblastoma | Neurology